Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Echo IQ's change in receivables for the quarter that ended in Dec. 2025 was $0.00 Mil. It means Echo IQ's Accounts Receivable
stayed the same
from Jun. 2025 to Dec. 2025 .
Echo IQ's change in receivables for the fiscal year that ended in Jun. 2025 was $0.00 Mil. It means Echo IQ's Accounts Receivable
stayed the same
from Jun. 2024 to Jun. 2025 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Echo IQ's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 209.88.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Echo IQ's liquidation value for the
six
months ended in Dec. 2025 was $7.02 Mil.
Echo IQ (OTCPK:ECHQF) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Echo IQ's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Echo IQ Change In Receivables Related Terms
Echo IQ Change In Receivables Historical Data
* Premium members only.
The historical data trend for Echo IQ's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of $0.00 Mil mean?
Echo IQ (ECHQF) has a Change In Receivables of $0.00 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Echo IQ and its competitors.
Is Echo IQ's Change In Receivables too high?
Echo IQ's current Change In Receivables is $0.00 Mil. Overall, Echo IQ has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Echo IQ's Change In Receivables compare to VEEV and BTSG?
Echo IQ's Change In Receivables of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Echo IQ and its competitors. Echo IQ's current Change In Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Echo IQ stock overvalued right now?
Based on GuruFocus' analysis, Echo IQ (ECHQF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $1.25 — trading 6150% above its estimated fair value. The current Change In Receivables is $0.00 Mil. Echo IQ's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Echo IQ (ECHQF), the current Change In Receivables is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Echo IQ (ECHQF) Overvalued in 2026?
Based on GuruFocus' analysis, Echo IQ stock appears to be overvalued.
The current stock price of $1.25 is trading 6150% above its estimated GF Value™ of $0.02.
GuruFocus considers Echo IQ to be Significantly Overvalued.
Key valuation signals for ECHQF:
Change In Receivables: $0.00 Mil
GF Value™: $0.02 vs. price of $1.25 (6150% above fair value)
No single metric tells the full story. See the ECHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
13GF Score
Get the complete analysis for ECHQF
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ECHQF has been successfully added to your 
